News and Announcements

Vector Biolabs strives to be on the cutting edge of viral vector production.  Our staff, dedicated to improving our products and services, is always innovating and exploring new findings in the scientific literature.  In an effort, as always, to engage and communicate with our customers, this page will be updated with the most recent news and announcements about our business.

A Guide to AAV Serotype Selection

A summary of the known tissue tropism and characteristics of the naturally occurring AAV serotypes.

Vector Biolabs Expands Viral Vector Manufacturing Capacity and Adds to QC Capabilities 

Leading discovery-stage manufacturer of adeno-associated virus (AAV) and adenovirus viral vectors doubles lab space and now offers a more comprehensive range of support for preclinical development.  MALVERN, PA – May 10, 2023 – Vector Biolabs, a custom design and manufacturing service provider for AAV and adenovirus viral vectors announced the completion of a facility expansion […]

An Update on COVID-19

To all of our valued customers,     Vector Biolabs is closely monitoring the COVID-19 situation across the globe.  While our labs are now in an affected area, we recognize that our work is vital to research communities worldwide.  Therefore, we will still be accepting new orders and continuing viral production for the foreseeable future.     […]

We Have Redesigned Our Website!

Our New Lab